Financial Daily from THE HINDU group of publications
Thursday, Mar 25, 2004

Cross Currency

Group Sites

Corporate - IPOs

Dishman Pharma price band at Rs 155-175

Our Bureau

Ahmedabad , March 24

DISHMAN Pharmaceuticals and Chemicals Ltd (DPCL) has kept its price band of Rs 155-175 per equity share for its forthcoming IPO.

The issue that opens on March 29 and closes on April 7 is looking to raise Rs 53 crore-60 crore.

The Ahmedabad-based Dishman is a specialised chemicals manufacturer of quats (ammonium and phosphonium quaternary compounds). It has also gone in for contract manufacturing and APIs/ intermediates for overseas clients, including some of the big names such as DuPont, Dow Chemicals, Mobil and Solvay.

DPCL posted sales of Rs 114.4 crore for the last fiscal and a net profit of Rs 14.3 crore. Against this, the DPCL sales during the first half of the current fiscal were Rs 52.1 crore.

However, company officials said that the first six months constituted only 40 per cent of sales in a typical year.

"The company has identified a number of molecules that go off the patent regime over the next five years for generic development.

Also, contract manufacturing and contract research are emerging as big volume business for specialised companies such as ours.

The US and European markets are growing at such a pace that we are struggling to keep the Indian share of 18 per cent in tact.

More Stories on : IPOs | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
HMSIL to roll out first motorcycle in October

RPG Enterprises to fund Saregama's film ventures
Cipla board okays stock split
Indian Rayon meet on allotment of shares
Addl Director on NCCL board
Alok Ind mulls pref issues
Spectrum shareholder files petition seeking share freeze
Moody's upgrades Tata Motors outlook to positive
Transgene approval for Saket merger
Alka Spinners board meet to discuss merger
Welspun Gujarat to invest Rs 200 cr in new capacity
Haldia to be manufacturing base for Russian UralAZ
Dishman Pharma price band at Rs 155-175
CM's intervention sought to resolve Maha Scooters issue
Electrolux spruces up supply-chain management
New control tech powers BHEL business
Hyundai sales likely to rise 47 pc
Saregama plans tie-ups for music download

The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright 2004, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line